Clinical Trial Update: Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of montelukast on doxorubicin-induced cardiotoxicity in patients with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Damanhour University | Conditions: Breast Cancer, Doxorubicin Induced Cardiotoxicity | NA | Status: COMPLETED